Clinical Trials on Borderline Resectable Adenocarcinoma of the Head of the Pancrease
Total 9779 results
-
BiogenCompletedRelapsing Remitting Multiple SclerosisPortugal
-
University of Milano BicoccaWithdrawnMultiple Sclerosis, Relapsing-RemittingItaly
-
Ospedale Policlinico San MartinoActive, not recruiting
-
Universitätsklinikum Hamburg-EppendorfHeinrich-Heine University, Duesseldorf; University of Cologne; University Medical... and other collaboratorsCompletedMultiple Sclerosis, Relapsing-RemittingGermany
-
Novartis PharmaceuticalsCompleted
-
Beijing InnoCare Pharma Tech Co., Ltd.Active, not recruitingRelapsing Remitting Multiple SclerosisChina, United States, Ukraine, Poland
-
Assiut UniversityCompletedGuillain-Barre SyndromeEgypt
-
Johns Hopkins UniversityGlaxoSmithKlineTerminatedMultiple SclerosisUnited States
-
University of MichiganCompleted
-
TG Therapeutics, Inc.Completed
-
Assiut UniversityCompletedRelapsing Remitting Multiple SclerosisEgypt
-
Firat UniversityCompletedRelapsing Remitting Multiple SclerosisTurkey
-
Genzyme, a Sanofi CompanyCompletedRelapsing Remitting Multiple SclerosisUnited States, Argentina, Australia, Belgium, Brazil, Canada, Czechia, Denmark, Germany, Israel, Italy, Mexico, Netherlands, Poland, Russian Federation, Spain, Sweden, Ukraine, United Kingdom
-
Gliknik Inc.CompletedSquamous Cell Carcinoma of the Oral CavityUnited States, Hungary, Ukraine, Russian Federation, Serbia, Poland, Spain
-
Providence Health & ServicesGenentech, Inc.CompletedRelapsing Remitting Multiple SclerosisUnited States
-
Banner Life Sciences LLCWithdrawnRelapsing Remitting Multiple Sclerosis
-
University of AarhusUniversity of Southern Denmark; Jascha fund; Knud and Edith Eriksens memorial... and other collaboratorsCompletedMultiple Sclerosis | Cognitive Impairment | Brain AtrophyDenmark
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedPulmonary Hypertension, Persistent, of the NewbornUnited Kingdom
-
BiogenAlkermes, Inc.CompletedRelapsing Remitting Multiple SclerosisUnited States, Germany, Poland
-
Teva Pharmaceutical Industries, Ltd.TerminatedRelapsing Remitting Multiple SclerosisCzechia, Germany, Hungary, Israel, Italy, Poland, Russian Federation, Spain, United Kingdom
-
University of ChicagoGenzyme, a Sanofi CompanyCompleted
-
Stanford UniversityThe V Foundation for Cancer ResearchCompletedRecurrent Skin Cancer | Basal Cell Carcinoma of the SkinUnited States
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisHungary, Turkey, Spain, Germany, Canada, Switzerland, United States, Norway, Russian Federation, Italy, Finland, Poland
-
Charite University, Berlin, GermanyGerman Research Foundation; Pfizer; German Federal Ministry of Education and...CompletedRelapsing Remitting Multiple Sclerosis
-
Fondazione Italiana Sclerosi MultiplaOpera CRO, a TIGERMED Group CompanyCompletedMultiple Sclerosis | Neurodegenerative DiseasesItaly, Romania
-
Johns Hopkins UniversityCompletedRelapsing Remitting Multiple SclerosisUnited States
-
BiogenCompletedMultiple SclerosisUnited States, Italy, Hungary, United Kingdom, Spain, France, Australia, Germany, Canada, Switzerland, Argentina, Czech Republic, Croatia
-
Harvard Pilgrim Health CareKaiser Permanente; Aetna, Inc.; i3 Drug Safety; HealthCore, Inc.; Highmark Blue Cross...CompletedGuillain-Barre SyndromeUnited States
-
Novartis PharmaceuticalsCompletedMultiple SclerosisRussian Federation, Ukraine, Czech Republic
-
Isfahan University of Medical SciencesCompletedRelapsing Remitting Multiple SclerosisIran, Islamic Republic of
-
BiogenGB Pharma Services & Consulting s.r.l.Withdrawn
-
Rocky Mountain MS Research Group, LLCBiogenCompletedRelapsing Remitting Multiple SclerosisUnited States
-
Novartis PharmaceuticalsCompletedMultiple SclerosisColombia, Panama, Peru, Brazil, Jordan, Malaysia, Mexico, Argentina
-
Apitope Technology (Bristol) Ltd.Aptiv Solutions; ClinStar, LLCCompletedRelapsing Remitting Multiple SclerosisUnited Kingdom, Russian Federation
-
BayerCompleted
-
Centre Hospitalier Universitaire de Saint EtienneLaboratoire français de Fractionnement et de BiotechnologiesCompletedDemyelinating PolyneuropathyFrance
-
Kuopio University HospitalCompletedRelapse-remitting Multiple SclerosisFinland
-
Neurotec PharmaAdvancell - Advanced In Vitro Cell Technologies, S.A.CompletedRelapsing Remitting Multiple SclerosisSpain, Germany
-
Tehran University of Medical SciencesCompletedRelapsing Remitting Multiple SclerosisIran, Islamic Republic of
-
Anna TsakiriSanofiWithdrawnRelapsing Remitting Multiple SclerosisDenmark
-
Merck KGaA, Darmstadt, GermanyCompleted
-
EMD SeronoMerck Serono International SACompletedMultiple Sclerosis, Relapsing-remitting
-
Tehran University of Medical SciencesUnknownRelapsing Remitting Multiple SclerosisIran, Islamic Republic of
-
NovartisCompletedMultiple SclerosisGreece, Russian Federation, Switzerland, Germany, Israel, Ireland, Belgium, Finland, United Kingdom, Netherlands, Canada, Romania, Hungary, Poland, Czech Republic, Australia, Estonia, France, Slovakia, South Africa, Sweden, Turkey
-
GlaxoSmithKlineCompletedMultiple SclerosisItaly, Germany, Spain, United Kingdom, Australia, Netherlands, New Zealand, Russian Federation, France, Canada, Austria, Poland, Finland, Norway
-
University at BuffaloBiogenCompletedMultiple SclerosisUnited States
-
Charite University, Berlin, GermanyUnknownMultiple Sclerosis, MS | Clinically Isolated SyndromeGermany
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedRelapsing Remitting Multiple Sclerosis
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedRelapsing Remitting Multiple Sclerosis
-
Bristol-Myers SquibbTerminated